Is 1-Month Dual Antiplatelet Therapy Applicable to Any Type of Drug-Eluting Stent in Any Clinical Scenario?

Circ J. 2024 May 24;88(6):885-887. doi: 10.1253/circj.CJ-24-0287. Epub 2024 Apr 26.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Drug Administration Schedule
  • Drug-Eluting Stents*
  • Dual Anti-Platelet Therapy*
  • Humans
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors* / administration & dosage
  • Platelet Aggregation Inhibitors* / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors